Please login to the form below

Not currently logged in

Healthcare prevention plan worthy, but funding an issue

Aims to boost national life expectancy by five years

Matt Hancock

Health Secretary Matt Hancock has issued a call for the NHS to place a greater emphasis on disease prevention to try to boost the national life expectancy by five years.

A new vision document sets the broad strokes for meeting that target – set for 2035 – and will be followed by a Green Paper next year that Hancock said will provide the important details. It also wants to see childhood obesity halved by 2030, extending healthcare workers’ ability to ‘prescribe’ community activities to help tackle loneliness, and deploy technology to help predict illness

Overall, the focus is on changing lifestyle habits like diet, exercise and sleep, taking action on mental health, and gearing up the NHS to pick up health issues and provide care sooner – for example it wants three quarters of cancers to be diagnosed at earlier stages (I or II) by 2028.

There’s also a strong emphasis on people taking responsibility after their own health and receiving care in the community rather than hospital, all in the hope of “slowing the growth in demands on the NHS and making it sustainable for future generations,” says the document, “whilst closing the gap between the richest and poorest.”

It goes on to say that the health and social care services need to fundamentally change to allow this to happen, and society as a whole has to get involved, for example bosses should do more to encourage their workers to stay healthy, local government should help encourage walking and cycling, and schools working more closely with mental health services to help young people stay mentally well.

The document has been warmly welcomed by the NHS Confederation. Its chief executive, Niall Dickson, said that this could be a “seminal moment” for the UK – provided the ambition is “backed by action and resources.”

“Of course, we have been here before and the recent record of cutting public health spending must now be reversed,” he continued, pointing out that local government was given responsibility for public health in 2012 and since then has seen swingeing cuts in their budgets.

Moreover, while the government has been trumpeting the £20.5bn as “the single largest cash injection for the NHS ever”, it is important to note that “excluded central funds for public health, making the percentage seem larger and suggesting that public health was not a priority,” said Dickson.

The British Medical Association (BMA) has taken a similar stance, calling for the proposals “to be matched with investment to enable tougher action on the driving factors behind preventable ill-health.”

BMA public health committee chair, Dr Peter English, said that the plans “are a welcome step [but] the government must be realistic about what must be required in order to deliver this.”

“There is a need to reserve the cuts to public health budgets, as in many areas, public health services do not adequately meet the health needs of the local population,” he said. “Reductions to services such as smoking cessation and sexual health in some areas are directly contributing to unacceptable variations in the quality and quantity of care available to the population.”

The future funding for Public Health England is currently an unknown quantity, and will not be revealed until the spending review next year.

Speaking on the BBC’s Today programme, Hancock was tight-lipped about how much of the £20.5bn might go towards preventive measures, but did say that he wants to see the proportion spent on primary care increase.

"In the UK, we are spending £97bn of public money on treating disease and only £8bn preventing it across the UK,” he said. "You don't have to be an economist to see those numbers don't stack up."

Article by
Phil Taylor

5th November 2018

From: Healthcare



Featured jobs

Subscribe to our email news alerts


Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...